Autem Therapeutics

Hanover, United States

Autem Therapeutics is an oncology therapeutic and bioelectric technology company which provides cancer care.

$10.0M raised

Jun 2022

Series A

Biotechnology Health Care Oncology

Top Investors

Zentynel Frontier Investments

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Autem Therapeutics

How much funding has Autem Therapeutics raised?

Autem Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.

Who are Autem Therapeutics's investors?

Autem Therapeutics's investors include Zentynel Frontier Investments.

Where is Autem Therapeutics headquartered?

Autem Therapeutics is headquartered in Hanover, United States.

What does Autem Therapeutics do?

Autem Therapeutics is an oncology therapeutic and bioelectric technology company which provides cancer care.

What stage is Autem Therapeutics at?

Autem Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 6, 2022.

MLA

"Autem Therapeutics — Funding & Investors." VCBacked, June 6, 2022, https://www.vcbacked.co/company/autem-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Autem Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/autem-therapeutics

Wikipedia (cite web)

{{cite web |title=Autem Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/autem-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 6, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K